• Nenhum resultado encontrado

[PDF] Top 20 Targeted therapies in breast cancer

Has 10000 "Targeted therapies in breast cancer" found on our website. Below are the top 20 most common "Targeted therapies in breast cancer".

Targeted therapies in breast cancer

Targeted therapies in breast cancer

... that in vivo results, where HER-2 overexpressed mouse had a greater apoptosis effect, with designed drug, compared with a HER-2 cell line with normal expression ...target therapies due to its targeting ... See full document

52

Significance of Cancer Stem Cells in Anti-Cancer Therapies

Significance of Cancer Stem Cells in Anti-Cancer Therapies

... The cancer stem cell is related to but not identical to the normal ...found in cell markers that will differentiate solid tumor stem cells from normal stem ...are in a position to compare the ... See full document

5

Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility.

Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility.

... Breast cancer is the most common malignancy among women, and the contribution of heredi- tary susceptibility to its development has been well ...Numerous breast cancer sus- ceptibility genes ... See full document

14

Cancer stem cells in prostate cancer: implications for targeted therapy

Cancer stem cells in prostate cancer: implications for targeted therapy

... mentioned in this ...tested in patients with metastatic disease for whom all other therapies have been ineffective (phase I ...is in- volved in androgen-independent mechanisms and bone ... See full document

12

Unraveling FATP1, regulated by ER-β, as a targeted breast cancer innovative therapy

Unraveling FATP1, regulated by ER-β, as a targeted breast cancer innovative therapy

... of cancer metabolism for cancer detection and treatment is a promising strategy in cancer therapeutics, diagnosis and prevention 52 .... In many tumors like melanoma, breast and ... See full document

15

Targeted Fluoromagnetic Nanoparticles for Imaging of Breast Cancer MCF-7 Cells

Targeted Fluoromagnetic Nanoparticles for Imaging of Breast Cancer MCF-7 Cells

... of benzyl ether and oleylamine (30 mL: 30 mL) and were stirred by magnetic stirrer. 21-23 The solution was dehydrated at 120 °C for 1h using Dean-Stark apparatus and under flow of argon. After 1 h, temperature was raised ... See full document

7

Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.

Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.

... growing in mice injected with 29- O-methyl CONT2 siRNA-transfected ...grown in mice treated with MPA were ductal mammary carcinomas composed of solid pseudolobules of highly cohesive glandular cells that ... See full document

12

Ets2 in tumor fibroblasts promotes angiogenesis in breast cancer.

Ets2 in tumor fibroblasts promotes angiogenesis in breast cancer.

... partners in tumor progression, but the genes and pathways that mediate this collaboration are ...function in stromal cells significantly contributes to breast tumor ...Ets2 in both mammary ... See full document

11

EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice.

EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice.

... described in this study has yielded the most effective treatment of EGFR over- expressing GBM reported so far, in an animal ...EGFR targeted agents aimed at GBM, such as erlotinib, gefitinib, [20] and ... See full document

11

Tumor microenvironment models: ex vivo, in vitro and in silico approaches to address targeted therapies

Tumor microenvironment models: ex vivo, in vitro and in silico approaches to address targeted therapies

... the cancer cells, as suggested by the sustained detection of CK-18 and ...decrease in spheroid ...agitation in the non- encapsulated spheroids, and avoided by the space limitation imposed by the ... See full document

270

Impaired OXPHOS complex III in breast cancer.

Impaired OXPHOS complex III in breast cancer.

... involved in mtOXPHOS are encoded by the mitochondrial DNA ...are targeted to the mitochondria by a mitochondrial targeting ...that cancer cells have an irreversible injury to respiration that leads ... See full document

10

Clinical decisions in breast cancer, a heterogenous disease

Clinical decisions in breast cancer, a heterogenous disease

... [76]. In Beatrice, unlike ECOG 5103, the safety data did not require premature termination of the trial, therefore efficacy results of bevacizumab in the adjuvant setting in the TNBC subtype are ... See full document

147

Current options in breast cancer targeted therapies: life after HER-2.

Current options in breast cancer targeted therapies: life after HER-2.

... hand, breast cancer is a very heterogeneous and complex disease, making the choice of treatment not usually an easy ...pick. Targeted therapies are generally very selective by nature, which ... See full document

35

Synergy between antiangiogenic and immuno-therapies in breast cancer

Synergy between antiangiogenic and immuno-therapies in breast cancer

... converted in .tif format. In these pictures, displaying the entire tumor section, color deconvolution was applied, separating the Hematoxylin and Eosin channels, and the Huang threshold method was used to ... See full document

86

Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapies

Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapies

... Figure 2. Drugs targeting HER2 and/or HER3. There are two main groups of drugs represented: monoclonal antibodies targeting the extracellular domains and tyrosine kinase inhibitors that bind to the receptor kinases ... See full document

39

Targeted therapies for triple-negative breast cancer

Targeted therapies for triple-negative breast cancer

... blocked in a 5% milk blocking solution in ...1:1000 in blocking buffer, with constant shaking, at 4º C ...each) in PBS-T, followed by the incubation with the appropriate secondary antibody ... See full document

89

Fracture risk and adjuvant therapies in young breast cancer patients: a population-based study.

Fracture risk and adjuvant therapies in young breast cancer patients: a population-based study.

... adjuvant therapies including selective estrogen receptor modulator (tamoxi- fen), AIs (anastrozole, letrozole, and exemestane), monoclonal antibody (trastuzumab), che- motherapy, and radiotherapy according to ... See full document

10

Policies and programs to facilitate access to targeted cancer therapies in Thailand.

Policies and programs to facilitate access to targeted cancer therapies in Thailand.

... up in Thailand since January 2003 by Novartis Co ...gaps in access for eligible patients who could not afford the costly ...involved in all stages of treatment, including di- agnosis, prescription, ... See full document

17

Lymphedema in women undergoing breast cancer surgery

Lymphedema in women undergoing breast cancer surgery

... lymph in the interstitium, is a serious morbidity which, if not pre- vented or treated properly, results in significant im- pairment of the affected ... See full document

8

Pregnancy and its role in breast cancer

Pregnancy and its role in breast cancer

... mary gland [24]. Despite differentiation, the mammary epithelium remains capable of responding with prolifera- tion to a given stimuli, such as a new pregnancy. Under these circumstances, however, the cells that are ... See full document

5

Show all 10000 documents...

temas relacionados